0
0
37 words
0
Comments
Successful trial of the NmCV-5 pentavalent vaccine suggests it could contribute to the goal of defeating epidemic meningitis by 2030.
You are the first to view
https://www.gavi.org/vaccineswork/vaccine-trial-boosts-hope-eliminating-meningococcal-disease-sub-saharan-africa
Create an account or login to join the discussion